Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis

Nobuhiro Hata, Koji Yoshimoto, Nobuhiko Yokoyama, Masahiro Mizoguchi, Tadahisa Shono, Yanlei Guan, Tomoko Tahira, Yoji Kukita, Koichiro Higasa, Shinji Nagata, Toru Iwaki, Tomio Sasaki, Kenshi Hayashi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Detection of loss of heterozygosity (LOH) in clinical tissue samples is frequently difficult because samples are usually contaminated with noncancerous cells or because tumor cells in single tissues have genetic heterogeneity, and the precision of available techniques is insufficient for reliable analysis in such materials. We hypothesized that single-strand conformation polymorphism (SSGP) analysis can precisely quantify the gene dosage in mixed samples and is suitable for detection of LOH in clinical tissue samples. Methods: We assessed the accuracy of a fluorescent SSCP method for the quantification of single-nucleotide polymorphism (SNP) alleles, using DNAs that were composed of cancerous DNA mixed with noncancerous DNA at various ratios. We applied this method to precisely characterize LOH in glioma tissue samples, using 96 SNPs that were evenly distributed throughout chromosome 10. Results: LOH could be detected even in the cancerous DNA heavily contaminated (up to 80%) with noncancerous DNA. Using this method, we obtained LOH profiles of 56 gliomas with resolutiqn at the SNP level (i.e., 1.5-Mbp interval). Anaplastic astrocytomas exhibited both 10p and 10q LOH, whereas diffuse astrocytomas frequently (63% of the cases) exhibited loss of 10p alone. We also found a possible new LOH region (around 10p13) in gliomas. Conclusions: The present method is effective for precise mapping of LOH region in surgically obtained tumor tissues and could be applicable to the genetic diagnosis of cancers other than gliomas.

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalClinical Chemistry
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 1 2006

Fingerprint

Chromosomes, Human, Pair 10
Loss of Heterozygosity
Chromosomes
Polymorphism
Glioma
Conformations
Tissue
DNA
Single Nucleotide Polymorphism
Astrocytoma
Tumors
Nucleotides
Single-Stranded Conformational Polymorphism
Neoplasms
Gene Dosage
Genetic Heterogeneity
Alleles
Genes
Cells

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. / Hata, Nobuhiro; Yoshimoto, Koji; Yokoyama, Nobuhiko; Mizoguchi, Masahiro; Shono, Tadahisa; Guan, Yanlei; Tahira, Tomoko; Kukita, Yoji; Higasa, Koichiro; Nagata, Shinji; Iwaki, Toru; Sasaki, Tomio; Hayashi, Kenshi.

In: Clinical Chemistry, Vol. 52, No. 3, 01.03.2006, p. 370-378.

Research output: Contribution to journalArticle

Hata, N, Yoshimoto, K, Yokoyama, N, Mizoguchi, M, Shono, T, Guan, Y, Tahira, T, Kukita, Y, Higasa, K, Nagata, S, Iwaki, T, Sasaki, T & Hayashi, K 2006, 'Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis', Clinical Chemistry, vol. 52, no. 3, pp. 370-378. https://doi.org/10.1373/clinchem.2005.060954
Hata, Nobuhiro ; Yoshimoto, Koji ; Yokoyama, Nobuhiko ; Mizoguchi, Masahiro ; Shono, Tadahisa ; Guan, Yanlei ; Tahira, Tomoko ; Kukita, Yoji ; Higasa, Koichiro ; Nagata, Shinji ; Iwaki, Toru ; Sasaki, Tomio ; Hayashi, Kenshi. / Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. In: Clinical Chemistry. 2006 ; Vol. 52, No. 3. pp. 370-378.
@article{a65f5e1cc322417fae978e6e2334290a,
title = "Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis",
abstract = "Background: Detection of loss of heterozygosity (LOH) in clinical tissue samples is frequently difficult because samples are usually contaminated with noncancerous cells or because tumor cells in single tissues have genetic heterogeneity, and the precision of available techniques is insufficient for reliable analysis in such materials. We hypothesized that single-strand conformation polymorphism (SSGP) analysis can precisely quantify the gene dosage in mixed samples and is suitable for detection of LOH in clinical tissue samples. Methods: We assessed the accuracy of a fluorescent SSCP method for the quantification of single-nucleotide polymorphism (SNP) alleles, using DNAs that were composed of cancerous DNA mixed with noncancerous DNA at various ratios. We applied this method to precisely characterize LOH in glioma tissue samples, using 96 SNPs that were evenly distributed throughout chromosome 10. Results: LOH could be detected even in the cancerous DNA heavily contaminated (up to 80{\%}) with noncancerous DNA. Using this method, we obtained LOH profiles of 56 gliomas with resolutiqn at the SNP level (i.e., 1.5-Mbp interval). Anaplastic astrocytomas exhibited both 10p and 10q LOH, whereas diffuse astrocytomas frequently (63{\%} of the cases) exhibited loss of 10p alone. We also found a possible new LOH region (around 10p13) in gliomas. Conclusions: The present method is effective for precise mapping of LOH region in surgically obtained tumor tissues and could be applicable to the genetic diagnosis of cancers other than gliomas.",
author = "Nobuhiro Hata and Koji Yoshimoto and Nobuhiko Yokoyama and Masahiro Mizoguchi and Tadahisa Shono and Yanlei Guan and Tomoko Tahira and Yoji Kukita and Koichiro Higasa and Shinji Nagata and Toru Iwaki and Tomio Sasaki and Kenshi Hayashi",
year = "2006",
month = "3",
day = "1",
doi = "10.1373/clinchem.2005.060954",
language = "English",
volume = "52",
pages = "370--378",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "3",

}

TY - JOUR

T1 - Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis

AU - Hata, Nobuhiro

AU - Yoshimoto, Koji

AU - Yokoyama, Nobuhiko

AU - Mizoguchi, Masahiro

AU - Shono, Tadahisa

AU - Guan, Yanlei

AU - Tahira, Tomoko

AU - Kukita, Yoji

AU - Higasa, Koichiro

AU - Nagata, Shinji

AU - Iwaki, Toru

AU - Sasaki, Tomio

AU - Hayashi, Kenshi

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Background: Detection of loss of heterozygosity (LOH) in clinical tissue samples is frequently difficult because samples are usually contaminated with noncancerous cells or because tumor cells in single tissues have genetic heterogeneity, and the precision of available techniques is insufficient for reliable analysis in such materials. We hypothesized that single-strand conformation polymorphism (SSGP) analysis can precisely quantify the gene dosage in mixed samples and is suitable for detection of LOH in clinical tissue samples. Methods: We assessed the accuracy of a fluorescent SSCP method for the quantification of single-nucleotide polymorphism (SNP) alleles, using DNAs that were composed of cancerous DNA mixed with noncancerous DNA at various ratios. We applied this method to precisely characterize LOH in glioma tissue samples, using 96 SNPs that were evenly distributed throughout chromosome 10. Results: LOH could be detected even in the cancerous DNA heavily contaminated (up to 80%) with noncancerous DNA. Using this method, we obtained LOH profiles of 56 gliomas with resolutiqn at the SNP level (i.e., 1.5-Mbp interval). Anaplastic astrocytomas exhibited both 10p and 10q LOH, whereas diffuse astrocytomas frequently (63% of the cases) exhibited loss of 10p alone. We also found a possible new LOH region (around 10p13) in gliomas. Conclusions: The present method is effective for precise mapping of LOH region in surgically obtained tumor tissues and could be applicable to the genetic diagnosis of cancers other than gliomas.

AB - Background: Detection of loss of heterozygosity (LOH) in clinical tissue samples is frequently difficult because samples are usually contaminated with noncancerous cells or because tumor cells in single tissues have genetic heterogeneity, and the precision of available techniques is insufficient for reliable analysis in such materials. We hypothesized that single-strand conformation polymorphism (SSGP) analysis can precisely quantify the gene dosage in mixed samples and is suitable for detection of LOH in clinical tissue samples. Methods: We assessed the accuracy of a fluorescent SSCP method for the quantification of single-nucleotide polymorphism (SNP) alleles, using DNAs that were composed of cancerous DNA mixed with noncancerous DNA at various ratios. We applied this method to precisely characterize LOH in glioma tissue samples, using 96 SNPs that were evenly distributed throughout chromosome 10. Results: LOH could be detected even in the cancerous DNA heavily contaminated (up to 80%) with noncancerous DNA. Using this method, we obtained LOH profiles of 56 gliomas with resolutiqn at the SNP level (i.e., 1.5-Mbp interval). Anaplastic astrocytomas exhibited both 10p and 10q LOH, whereas diffuse astrocytomas frequently (63% of the cases) exhibited loss of 10p alone. We also found a possible new LOH region (around 10p13) in gliomas. Conclusions: The present method is effective for precise mapping of LOH region in surgically obtained tumor tissues and could be applicable to the genetic diagnosis of cancers other than gliomas.

UR - http://www.scopus.com/inward/record.url?scp=33644558037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644558037&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2005.060954

DO - 10.1373/clinchem.2005.060954

M3 - Article

VL - 52

SP - 370

EP - 378

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 3

ER -